Assoc. Prof. Dr Atsushi Hinenoya – Molecular epidemiology of pathogenic bacteria – Best Researcher Award

Assoc. Prof. Dr Atsushi Hinenoya - Molecular epidemiology of pathogenic bacteria - Best Researcher Award

Osaka Metropolitan University - Japan

Author Profile 

SCOPUS 

🌱 Early academic pursuits

Atsushi Hinenoya embarked on his academic journey with a deep passion for veterinary science and microbiology. he earned his ph.d. in 2009 from the department of veterinary science at the graduate school of life and environmental sciences, osaka prefectural university, japan. during this time, he delved into complex microbial research, laying the foundation for his career as an esteemed microbiologist and academic leader.

🏫 Professional endeavors

Dr. Hinenoya’s professional career began in 2009 as an assistant professor at osaka prefectural university, where he dedicated nearly a decade to teaching and research. his commitment and expertise earned him a promotion to associate professor in 2017. between 2017 and 2019, he expanded his international experience as a visiting scholar at the department of animal science, university of tennessee, usa. in 2022, he joined osaka metropolitan university as an associate professor in the department of veterinary science, where he continues to contribute to advancing veterinary microbiology.

🔬 Contributions and research focus

Throughout his career, dr. hinenoya has focused on understanding zoonotic pathogens, specifically escherichia coli and escherichia albertii. his completed research projects have addressed Molecular epidemiology of pathogenic bacteria molecular epidemiology, colistin resistance, and horizontal gene transfer in e. coli. currently, his ongoing studies aim to develop novel detection methods, analyze virulence mechanisms, and explore the transmission dynamics of e. albertii. his contributions to the field are evident through his published works and two patents, including an innovative method for producing disinfected liver.

🏆 Accolades and recognition

Dr. Hinenoya’s groundbreaking research has earned him several prestigious awards. he received research encouragement awards in 2011 and 2016 from the japanese symposium for Molecular epidemiology of pathogenic bacteria enterohemorrhagic e. coli infectious diseases. in 2021, he was honored with the young scientist award by the japanese society for bacteriology, further solidifying his reputation as a leader in the field of bacteriology.

🌍 Impact and influence

With a citation index of 26 in scopus, dr. hinenoya’s work has significantly influenced the scientific community, particularly in veterinary microbiology and zoonotic pathogen research. his Molecular epidemiology of pathogenic bacteria consultancy projects with taiko pharmaceutical have contributed to the development of effective disinfection methods against multidrug-resistant bacteria and foodborne pathogens, demonstrating the practical application of his research in public health and food safety.

💡 Legacy and future contributions

Dr. Hinenoya’s legacy lies in his unwavering commitment to combating zoonotic diseases and advancing veterinary microbiology. as he continues his research on e. albertii and other emerging pathogens, his work promises to shape the future of microbial science and public health. his dedication to mentoring young scientists and collaborating with international institutions ensures that his contributions will have a lasting impact on the field.

Notable Publications 

  • Title: Occurrence and cross contamination of Escherichia albertii in retail chicken outlets in Bangladesh
    Authors: Hassan, J., Utsho, K.S., Karmakar, S., Yamasaki, S., Hinenoya, A.
    Journal: International Journal of Food Microbiology, 2025, 431, 111081
  • Title: Prevalence of potentially pathogenic and antimicrobial-resistant Escherichia coli in raw milk and dairy products in Egypt
    Authors: Elbastawesy, A.M., Awasthi, S.P., Hatanaka, N., Deeb, A.M.M., Yamasaki, S.
    Journal: International Dairy Journal, 2025, 162, 106145
  • Title: Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples
    Authors: Takehira, K., Manjunath, G.B., Hatanaka, N., Hinenoya, A., Yamasaki, S.
    Journal: International Journal of Food Microbiology, 2025, 430, 111057
  • Title: A plasmid-mediated type III secretion system associated with invasiveness and diarrheagenicity of Providencia rustigianii
    Authors: Hassan, J., Hinenoya, A., Hatanaka, N., Faruque, S.M., Yamasaki, S.
    Journal: mBio, 2024, 15(10)
  • Title: Detection of prolonged excretion of Escherichia albertii in stool specimens of a 7-year-old child by a newly developed Eacdt gene-based quantitative real-time PCR method and molecular characterization of the isolates
    Authors: Awasthi, S.P., Nagita, A., Hatanaka, N., Hinenoya, A., Yamasaki, S.
    Journal: Heliyon, 2024, 10(9), e30042

Dr. Angela Cano Yuste – Infectious DIseases – Best Researcher Award

Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award

Reina Sofia University Hospital/IMIBIC - Spain 

Author Profile 

SCOPUS 

Early academic pursuits 🎓

Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.

Professional endeavors 👨‍🌾

Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.

Contributions and research focus 🔧

Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.

Accolades and recognition 🌟

Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.

Impact and influence 🌍

Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.

Legacy and future contributions 🔄

Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..

Notable publications 

  • Title: Invasive aspergillosis in liver transplant recipients in the current era
    Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
    Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107
  • Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
    Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
    Journal: Antibiotics, 2024, 13(9), 792
  • Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
    Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
    Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141
  • Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
    Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
    Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385
  • Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
    Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
    Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230